Binding of cytochalasin B to platelets

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Cytochalasin B (CB) is a known inhibitor of glucose transporters and microfilament polymerization.
• Understanding CB binding mechanisms is crucial for its therapeutic and research applications.

Purpose of the Study:

• To characterize the binding sites and affinities of cytochalasin B in human platelets.
• To investigate the molecular interactions of CB with platelet components.

Main Methods:

• Analysis of [3H]cytochalasin B binding to intact human platelets, isolated platelet cytosol, and platelet membranes.
• Competition assays using D-galactose, D-glucose, L-glucose, and cytochalasin E (CE).

Main Results:

• Two classes of saturable binding sites (high- and low-affinity) were identified on intact platelets.
• Cytosol binding exhibited similar affinities and capacities to whole cells, unaffected by D-galactose.
• Membrane binding showed uniform affinity, partially inhibited by D-galactose and CE.
• Hypothesized cytosol binding to monomeric and polymerized actin.
• Hypothesized membrane binding to galactose transport sites.

Conclusions:

• Human platelets possess distinct high- and low-affinity binding sites for cytochalasin B.
• Cytosol binding is likely mediated by actin, while membrane binding may involve galactose transport mechanisms.